Global remodelling of cellular microenvironment due to loss of collagen VII

Molecular Systems Biology

Volumn 9, Issue , 2013, Pages

  Küttner, Victoria ^a,b   MacK, Claudia ^b   Rigbolt, Kristoffer T G ^a   Kern, Johannes S ^b   Schilling, Oliver ^a   Busch, Hauke ^a   Bruckner Tuderman, Leena ^a,b   Dengjel, Jörn ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

disease proteomics; extracellular matrix (ECM); mass spectrometry; MMP14; primary human fibroblasts

Indexed keywords

COLLAGEN TYPE 7; MATRIX PROTEIN; METALLOPROTEINASE; PROTEINASE; PROTEOME; TRANSFORMING GROWTH FACTOR BETA; PROTEIN;

ADULT; ARTICLE; BASEMENT MEMBRANE; BIOINFORMATICS; CHILD; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; MICROENVIRONMENT; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; SCHOOL CHILD; SKIN; SKIN FRAGILITY; CASE CONTROL STUDY; CELL COMMUNICATION; DERMIS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETICS; INFANT; METABOLISM; NEWBORN; PATHOLOGY; PRIMARY CELL CULTURE; TUMOR MICROENVIRONMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INACTIVATION; GENODERMATOSIS; HUMAN TISSUE; MOLECULAR PATHOLOGY; PRIMARY CELL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; SKIN FIBROBLAST;

BASEMENT MEMBRANE; CASE-CONTROL STUDIES; CELL COMMUNICATION; CELLULAR MICROENVIRONMENT; COLLAGEN TYPE VII; DERMIS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; INFANT; INFANT, NEWBORN; MALE; METALLOPROTEASES; PRIMARY CELL CULTURE; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA;

EID: 84876580040     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2013.17     Document Type: Article

References (59)

1. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, Schneider H, Sadowski A, Riener MO, MacDougald OA, Distler O, Schett G, Distler JH (2012) Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 3: 735
2. auf demKeller U, Prudova A, Eckhard U, Fingleton B, Overall CM (2013) Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation. Sci Signal 6: rs2
3. Boraldi F, Bini L, Liberatori S, Armini A, Pallini V, Tiozzo R, Ronchetti IP, QuaglinoD(2003) Normal human dermalfibroblasts: proteomic analysis of cell layer and culture medium. Electrophoresis 24: 1292-1310 (Pubitemid 38088910)
4. Brizzi MF, Tarone G, Defilippi P (2012) Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr Opin Cell Biol 24: 645-651
5. Bruckner-Tuderman L, Nilssen O, Zimmermann DR, Dours-Zimmermann MT, Kalinke DU, Gedde-Dahl Jr T, Winberg JO (1995) Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol 131: 551-559
6. Butler GS, Overall CM (2009) Updated biological roles for matrix metalloproteinases and new 'intracellular' substrates revealed by degradomics. Biochemistry 48: 10830-10845
7. Chou MF, Schwartz D (2011) Biological sequence motif discovery using motif-x. Curr Protoc Bioinformatics Chapter 13: Unit 13. 15-24
8. Colombi M, Gardella R, Zoppi N, Moro L, Marini D, Spurr NK, Barlati S (1992) Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia. Hum Genet 89: 503-507
9. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367-1372
10. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10 : 1794-1805
11. Del Galdo F, Shaw MA, Jimenez SA (2010) Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis. Am J Pathol 177: 1638-1646
12. Desiere F, Deutsch EW, King NL, Nesvizhskii AI, Mallick P, Eng J, Chen S, Eddes J, Loevenich SN, Aebersold R (2006) The PeptideAtlas project. Nucleic Acids Res 34: D655-D658
13. Dix MM, Simon GM, Cravatt BF (2008) Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134: 679-691
14. Engelke R, Becker AC, Dengjel J (2012) The degradative inventory of the cell: proteomic insights. Antioxid Redox Signal 17: 803-812
15. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, McGrath JA, Mellerio JE, Murrell DF, Shimizu H, Uitto J, Vahlquist A, Woodley D, Zambruno G (2008) The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58: 931-950
16. Fritsch A, Loeckermann S, Kern JS, Braun A, Bosl MR, Bley TA, Schumann H, von Elverfeldt D, Paul D, Erlacher M, Berens von Rautenfeld D, Hausser I, Fassler R, Bruckner-Tuderman L (2008) A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118: 1669-1679 (Pubitemid 351632371)
17. Geiger T, Cox J, Ostasiewicz P, Wisniewski JR, Mann M (2010) Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods 7: 383-385
18. Gruhler A, Olsen JV, MohammedS,MortensenP,Faergeman NJ, Mann M, Jensen ON (2005) Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol Cell Proteomics 4: 310-327 (Pubitemid 40439774)
19. Hammami-Hauasli N, Schumann H, Raghunath M, Kilgus O, Luthi U, Luger T, Bruckner-Tuderman L (1998) Some, but not all, glycine substitution mutations in COL7A1 result in intracellular accumulation of collagen VII, loss of anchoring fibrils, and skin blistering. J Biol Chem 273: 19228-19234 (Pubitemid 28366322)
20. Han YP, Tuan TL, Wu H, Hughes M, Garner WL (2001) TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 114: 131-139 (Pubitemid 32118063)
21. Has C, Bruckner-Tuderman L (2006) Molecular and diagnostic aspects of genetic skin fragility. J Dermatol Sci 44: 129-144
22. Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, Kratchmarova I (2010) Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics 9: 2482-2496
23. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 81-92 (Pubitemid 29468632)
24. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57
25. Kern JS, Gruninger G, Imsak R, Muller ML, Schumann H, Kiritsi D, Emmert S, Borozdin W, Kohlhase J, Bruckner-Tuderman L, Has C (2009) Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort. Br J Dermatol 161: 1089-1097
26. Kern JS, Kohlhase J, Bruckner-Tuderman L, Has C (2006) Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. J Invest Dermatol 126: 1006-1012
27. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352-9360 (Pubitemid 24209266)
28. Loenarz C, Schofield CJ (2011) Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem Sci 36: 7-18
29. Loffek S, Schilling O, Franzke CW (2011) Series 'matrix metalloproteinases in lung health and disease': Biological role of matrix metalloproteinases: a critical balance. Eur Respir J 38: 191-208
30. Maquoi E, Peyrollier K, Noel A, Foidart JM, Frankenne F (2003) Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H\+-ATPases. Biochem J 373: 19-24 (Pubitemid 36819496)
31. Martins VL, Vyas JJ, Chen M, Purdie K, Mein CA, South AP, Storey A, McGrath JA, O'Toole EA (2009) Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J Cell Sci 122: 1788-1799
32. Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, Sell DR (2005) Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on 'a puzzle nearing resolution'. Ann NYAcad Sci 1043: 533-544 (Pubitemid 41123943)
33. Myllyharju J, Kivirikko KI (2004) Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 20: 33-43 (Pubitemid 38032818)
34. Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO (2012) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 11 : M111.014647
35. Ng YZ, Pourreyron C, Salas-Alanis JC, Dayal JH, Cepeda-Valdes R, Yan W, Wright S, Chen M, Fine JD, Hogg FJ, McGrath JA, Murrell DF, Leigh IM, Lane EB, South AP (2012) Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res 72: 3522-3534
36. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648 (Pubitemid 44647421)
37. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386
38. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2: 657-672 (Pubitemid 37328917)
39. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP (1992) A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 267: 17321-17326
40. Petersen TN, Brunak S, von Heijne G, Nielsen H (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8: 785-786
41. Pflieger D, Chabane S, Gaillard O, Bernard BA, Ducoroy P, Rossier J, Vinh J (2006) Comparative proteomic analysis of extracellular matrix proteins secreted by two types of skin fibroblasts. Proteomics 6: 5868-5879 (Pubitemid 44764023)
42. Rappsilber J, Mann M, Ishihama Y (2007) Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2: 1896-1906 (Pubitemid 47308128)
43. Schwartz D, Chou MF, Church GM (2009) Predicting protein post-translational modifications using meta-analysis of proteome scale data sets. Mol Cell Proteomics 8: 365-379
44. Schwartz D, Gygi SP (2005) An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 23: 1391-1398 (Pubitemid 41679391)
45. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860
46. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3
47. Sprenger A, Kuttner V, Biniossek ML, Gretzmeier C, Boerries M, Mack C, Has C, Bruckner-Tuderman L, Dengjel J (2010) Comparative quantitation of proteome alterations induced by aging or immortalization in primary human fibroblasts and keratinocytes for clinical applications. Mol Biosyst 6: 1579-1582
48. Sprenger A, Kuttner V, Bruckner-Tuderman L, Dengjel J (2013) Global proteome analyses of SILAC-labeled skin cells. Methods Mol Biol 961: 179-191
49. Titeux M, Pendaries V, Tonasso L, Decha A, Bodemer C, Hovnanian A (2008) A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum Mutat 29: 267-276 (Pubitemid 351240599)
50. Todorovic V, Desai BV, Eigenheer RA, Yin T, Amargo EV, Mrksich M, Green KJ, Patterson MJ (2010) Detection of differentially expressed basal cell proteins by mass spectrometry. Mol Cell Proteomics 9: 351-361
51. van den Akker PC, Jonkman MF, Rengaw T, Bruckner-Tuderman L, Has C, Bauer JW, Klausegger A, Zambruno G, Castiglia D, Mellerio JE, McGrath JA, van Essen AJ, Hofstra RM, Swertz MA (2011) The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat 32: 1100-1107
52. Vlodavsky I (2001) Preparation of extracellular matrices produced by cultured corneal endothelial and PF-HR9 endodermal cells. Curr Protoc Cell Biol Chapter 10: Unit 10.4
53. Waterman EA, Sakai N, Nguyen NT, Horst BA, Veitch DP, Dey CN, Ortiz-Urda S, Khavari PA, Marinkovich MP (2007) A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res 67: 4264-4270 (Pubitemid 46815073)
54. Watt FM, Fujiwara H (2011) Cell-extracellular matrix interactions in normal and diseased skin. Cold Spring Harb Perspect Biol 3(pii): a005124
55. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G (1996) The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271: 17119-17123 (Pubitemid 26244261)
56. Winberg JO, Gedde-Dahl Jr. T, Bauer EA (1989) Collagenase expression in skin fibroblasts from families with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 92: 82-85 (Pubitemid 19027696)
57. Wisniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6: 359-362
58. Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18: 1028-1040
59. Zimmermann AC, Zarei M, Eiselein S, Dengjel J (2010) Quantitative proteomics for the analysis of spatio-temporal protein dynamics during autophagy. Autophagy 6: 1009-1016